CLINICAL_TRIALS
trial_result
· 2019-03-22
Clinical Trial Update: Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) Patients [Phase 3]
Summary
Phase 3 trial evaluating serelaxin versus standard of care in acute heart failure was terminated with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Acute Heart Failure (AHF) | Phase 3 | Status: TERMINATED | Results posted: 2019-03-22